Cargando…
N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target
PURPOSE: N-myristoyltransferases 1 and 2 (NMT1 and NMT2) catalyze the addition of 14-carbon fatty acids to the N-terminus of proteins. Myristoylation regulates numerous membrane-bound signal transduction pathways important in cancer biology and the pan-NMT inhibitor PCLX-001 is approaching clinical...
Autores principales: | Mackey, John R., Lai, Justine, Chauhan, Utkarsh, Beauchamp, Erwan, Dong, Wei-Feng, Glubrecht, Darryl, Sim, Yie-Wei, Ghosh, Sunita, Bigras, Gilbert, Lai, Raymond, Berthiaume, Luc G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940342/ https://www.ncbi.nlm.nih.gov/pubmed/33398478 http://dx.doi.org/10.1007/s10549-020-06037-y |
Ejemplares similares
-
High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer
por: Gupta, Nidhi, et al.
Publicado: (2017) -
N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness
por: Frearson, Julie A., et al.
Publicado: (2010) -
SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension
por: Sun, Wei, et al.
Publicado: (2020) -
Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma
por: Sangha, Randeep, et al.
Publicado: (2022) -
A better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53 in vivo
por: Wang, Hui, et al.
Publicado: (2015)